187 related articles for article (PubMed ID: 31712311)
1. mTORC2 links growth factor signaling with epigenetic regulation of iron metabolism in glioblastoma.
Masui K; Harachi M; Ikegami S; Yang H; Onizuka H; Yong WH; Cloughesy TF; Muragaki Y; Kawamata T; Arai N; Komori T; Cavenee WK; Mischel PS; Shibata N
J Biol Chem; 2019 Dec; 294(51):19740-19751. PubMed ID: 31712311
[TBL] [Abstract][Full Text] [Related]
2. Glucose-dependent acetylation of Rictor promotes targeted cancer therapy resistance.
Masui K; Tanaka K; Ikegami S; Villa GR; Yang H; Yong WH; Cloughesy TF; Yamagata K; Arai N; Cavenee WK; Mischel PS
Proc Natl Acad Sci U S A; 2015 Jul; 112(30):9406-11. PubMed ID: 26170313
[TBL] [Abstract][Full Text] [Related]
3. Mammalian target of rapamycin complex 2 (mTORC2) controls glycolytic gene expression by regulating Histone H3 Lysine 56 acetylation.
Vadla R; Haldar D
Cell Cycle; 2018; 17(1):110-123. PubMed ID: 29143563
[TBL] [Abstract][Full Text] [Related]
4. mTORC2/AKT/HSF1/HuR constitute a feed-forward loop regulating Rictor expression and tumor growth in glioblastoma.
Holmes B; Benavides-Serrato A; Freeman RS; Landon KA; Bashir T; Nishimura RN; Gera J
Oncogene; 2018 Feb; 37(6):732-743. PubMed ID: 29059166
[TBL] [Abstract][Full Text] [Related]
5. Dual Regulation of Histone Methylation by mTOR Complexes Controls Glioblastoma Tumor Cell Growth via EZH2 and SAM.
Harachi M; Masui K; Honda H; Muragaki Y; Kawamata T; Cavenee WK; Mischel PS; Shibata N
Mol Cancer Res; 2020 Aug; 18(8):1142-1152. PubMed ID: 32366675
[TBL] [Abstract][Full Text] [Related]
6. Discrete signaling mechanisms of mTORC1 and mTORC2: Connected yet apart in cellular and molecular aspects.
Jhanwar-Uniyal M; Amin AG; Cooper JB; Das K; Schmidt MH; Murali R
Adv Biol Regul; 2017 May; 64():39-48. PubMed ID: 28189457
[TBL] [Abstract][Full Text] [Related]
7. mTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and upregulation of c-Myc.
Masui K; Tanaka K; Akhavan D; Babic I; Gini B; Matsutani T; Iwanami A; Liu F; Villa GR; Gu Y; Campos C; Zhu S; Yang H; Yong WH; Cloughesy TF; Mellinghoff IK; Cavenee WK; Shaw RJ; Mischel PS
Cell Metab; 2013 Nov; 18(5):726-39. PubMed ID: 24140020
[TBL] [Abstract][Full Text] [Related]
8. Involvement of mTORC1 and mTORC2 in regulation of glioblastoma multiforme growth and motility.
Gulati N; Karsy M; Albert L; Murali R; Jhanwar-Uniyal M
Int J Oncol; 2009 Oct; 35(4):731-40. PubMed ID: 19724909
[TBL] [Abstract][Full Text] [Related]
9. DNA hypomethylator phenotype reprograms glutamatergic network in receptor tyrosine kinase gene-mutated glioblastoma.
Harachi M; Masui K; Shimizu E; Murakami K; Onizuka H; Muragaki Y; Kawamata T; Nakayama H; Miyata M; Komori T; Cavenee WK; Mischel PS; Kurata A; Shibata N
Acta Neuropathol Commun; 2024 Mar; 12(1):40. PubMed ID: 38481314
[TBL] [Abstract][Full Text] [Related]
10. mTORC2-mediated direct phosphorylation regulates YAP activity promoting glioblastoma growth and invasive characteristics.
Holmes B; Benavides-Serrato A; Saunders JT; Kumar S; Nishimura RN; Gera J
Neoplasia; 2021 Sep; 23(9):951-965. PubMed ID: 34343821
[TBL] [Abstract][Full Text] [Related]
11. Nucleus-Translocated ACSS2 Promotes Gene Transcription for Lysosomal Biogenesis and Autophagy.
Li X; Yu W; Qian X; Xia Y; Zheng Y; Lee JH; Li W; Lyu J; Rao G; Zhang X; Qian CN; Rozen SG; Jiang T; Lu Z
Mol Cell; 2017 Jun; 66(5):684-697.e9. PubMed ID: 28552616
[TBL] [Abstract][Full Text] [Related]
12. Diverse signaling mechanisms of mTOR complexes: mTORC1 and mTORC2 in forming a formidable relationship.
Jhanwar-Uniyal M; Wainwright JV; Mohan AL; Tobias ME; Murali R; Gandhi CD; Schmidt MH
Adv Biol Regul; 2019 May; 72():51-62. PubMed ID: 31010692
[TBL] [Abstract][Full Text] [Related]
13. Distinct signaling mechanisms of mTORC1 and mTORC2 in glioblastoma multiforme: a tale of two complexes.
Jhanwar-Uniyal M; Gillick JL; Neil J; Tobias M; Thwing ZE; Murali R
Adv Biol Regul; 2015 Jan; 57():64-74. PubMed ID: 25442674
[TBL] [Abstract][Full Text] [Related]
14. mTORC2-mediated PDHE1α nuclear translocation links EBV-LMP1 reprogrammed glucose metabolism to cancer metastasis in nasopharyngeal carcinoma.
Zhang J; Jia L; Liu T; Yip YL; Tang WC; Lin W; Deng W; Lo KW; You C; Lung ML; Lung HL; Cheung AL; Tsao SW; Tsang CM
Oncogene; 2019 Jun; 38(24):4669-4684. PubMed ID: 30745576
[TBL] [Abstract][Full Text] [Related]
15. RES-529: a PI3K/AKT/mTOR pathway inhibitor that dissociates the mTORC1 and mTORC2 complexes.
Weinberg MA
Anticancer Drugs; 2016 Jul; 27(6):475-87. PubMed ID: 26918392
[TBL] [Abstract][Full Text] [Related]
16. ATP-site binding inhibitor effectively targets mTORC1 and mTORC2 complexes in glioblastoma.
Neil J; Shannon C; Mohan A; Laurent D; Murali R; Jhanwar-Uniyal M
Int J Oncol; 2016 Mar; 48(3):1045-52. PubMed ID: 26719046
[TBL] [Abstract][Full Text] [Related]
17. Carnosine inhibits glioblastoma growth independent from PI3K/Akt/mTOR signaling.
Oppermann H; Faust H; Yamanishi U; Meixensberger J; Gaunitz F
PLoS One; 2019; 14(6):e0218972. PubMed ID: 31247000
[TBL] [Abstract][Full Text] [Related]
18. mTORC2-AKT signaling to ATP-citrate lyase drives brown adipogenesis and de novo lipogenesis.
Martinez Calejman C; Trefely S; Entwisle SW; Luciano A; Jung SM; Hsiao W; Torres A; Hung CM; Li H; Snyder NW; Villén J; Wellen KE; Guertin DA
Nat Commun; 2020 Jan; 11(1):575. PubMed ID: 31996678
[TBL] [Abstract][Full Text] [Related]
19. mTOR complex-2 stimulates acetyl-CoA and de novo lipogenesis through ATP citrate lyase in HER2/PIK3CA-hyperactive breast cancer.
Chen Y; Qian J; He Q; Zhao H; Toral-Barza L; Shi C; Zhang X; Wu J; Yu K
Oncotarget; 2016 May; 7(18):25224-40. PubMed ID: 27015560
[TBL] [Abstract][Full Text] [Related]
20. mTORC2 activity in brain cancer: Extracellular nutrients are required to maintain oncogenic signaling.
Masui K; Shibata N; Cavenee WK; Mischel PS
Bioessays; 2016 Sep; 38(9):839-44. PubMed ID: 27427440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
